Document is current
Any future updates will be listed below
-
Authors
Harrison, Joseph D.
Dochney, Jessica A.
Blazekovic, Sonja
Leone, Frank
Metzger, David
Frank, Ian
Gross, Robert
Hole, Anita
Mounzer, Karam
Siegel, Steven
Schnoll, Robert A.
Ashare, Rebecca L.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (R01 DA033681)
National Institute on Drug Abuse (K23 DA035295)
National Institute of Allergy and Infectious Diseases (P30 AI045008)
National Institute of Mental Health (P30 MH097488)
- License Information
-
More Information
Article History
Received: 25 January 2017
Accepted: 13 March 2017
First Online: 20 April 2017
Compliance with ethical standards
:
: Dr. Schnoll receives medication and placebo free from Pfizer and has provided consultation to Pfizer and GlaxoSmithKline. These companies had no involvement in this study.Dr. Siegel has received grants and/or has acted as a consultant to Astellas, Merck, and Zynerba that is unrelated to the content of this manuscript.Dr. Gross sits on a Data Safety and Management Board for a Pfizer drug treating inflammatory bowel disease that is unrelated to the contents of this manuscript.
